secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2024-02-22T23:59:59+00:00
Accession:  0001493152-24-007546
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech Q4 revenue $17.7M, up 15.5% YoY; FY23 revenue $65.0M, up 41.8% YoY
--------------------------------------------------------------------------------

- Q4 net revenue $17.7M, +15.5% YoY; ninth consecutive record quarter.
- FY23 net revenue $65.0M, +41.8% YoY vs $45.8M in FY22.
- CellerateRX Surgical sales +31% YoY; growth driven by soft tissue repair and bone fusion products.
- Cash balance $5.1M as of Dec 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315224007546/0001493152-24-007546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315224007546/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer